Expertise in
5
conditions

Wilfried A. De Backer

Antwerpen, VLG, BE 
Expertise in
5
conditions
Antwerpen, VLG, BE 

Overview

Wilfried De Backer practices practicing medicine in Antwerpen, Belgium.

Mr. De Backer is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Bronchiolitis Obliterans, Lung Transplant, and Adenoidectomy.

He is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Antwerpen, VLG, Belgium
Other Locations
Kontich, VLG, Belgium
Wilrijk, VLG 2160, Belgium
Edegem, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Exploratory Study to Assess the Effect of Pulsed Inhaled Nitric Oxide on Functional Respiratory Imaging Parameters in Subjects With WHO Group 3 Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long Term Oxygen Therapy (LTOT).
Exploratory Study to Assess the Effect of Pulsed Inhaled Nitric Oxide on Functional Respiratory Imaging Parameters in Subjects With WHO Group 3 Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long Term Oxygen Therapy (LTOT).
Enrollment Status: Terminated
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Early Phase 1
An Exploratory, 3-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on Functional Pulmonary Imaging Parameters in Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long-Term Oxygen Therapy (LTOT) (Part 1) and in Subjects With WHO Group 3 PH Associated With Idiopathic Pulmonary Fibrosis (IPF) on LTOT (Part 2 and Part 3)
An Exploratory, 3-Part, Clinical Study to Assess the Effect of Pulsed, Inhaled Nitric Oxide (iNO) on Functional Pulmonary Imaging Parameters in Subjects With World Health Organization (WHO) Group 3 Pulmonary Hypertension (PH) Associated With Chronic Obstructive Pulmonary Disease (COPD) on Long-Term Oxygen Therapy (LTOT) (Part 1) and in Subjects With WHO Group 3 PH Associated With Idiopathic Pulmonary Fibrosis (IPF) on LTOT (Part 2 and Part 3)
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Phase 1
Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.
Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.
Enrollment Status: Terminated
Publish Date: March 21, 2018
Intervention Type: Drug, Radiation
Study Phase: Phase 2
Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)
Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)
Enrollment Status: Terminated
Publish Date: March 21, 2018
Intervention Type: Radiation
Study Phase: Phase 2
A Study to Assess the Effect of the Aerobika® Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using Functional Respiratory Imaging (FRI)
A Study to Assess the Effect of the Aerobika® Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using Functional Respiratory Imaging (FRI)
Enrollment Status: Completed
Publish Date: October 03, 2017
Intervention Type: Device, Radiation
Study Phase: Phase 4
View 4 Less Clinical Trials

84 Total Publications

Impact of benralizumab on airway structure/function in severe eosinophilic asthma.
Impact of benralizumab on airway structure/function in severe eosinophilic asthma.
Journal: Respiratory research
Published: February 25, 2026

Frequently Asked Questions about Wilfried A. De Backer

Is Wilfried A. De Backer a top-rated expert for Chronic Obstructive Pulmonary Disease (COPD)?

MediFind is an objective health platform that identifies experts based on real-world data. Wilfried A. De Backer is classified as an Distinguished expert for Chronic Obstructive Pulmonary Disease (COPD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wilfried A. De Backer participate in research or clinical trials?

Yes. Wilfried A. De Backer has published 84 articles and abstracts on conditions like Chronic Obstructive Pulmonary Disease (COPD). You can view a list of Wilfried A. De Backer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Backer's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile